Can the Dropout Risk of Candidates with Hepatocellular Carcinoma Predict Survival after Liver Transplantation?
β Scribed by A. Cucchetti; M. Cescon; V. Bertuzzo; E. Bigonzi; G. Ercolani; M. C. Morelli; M. Ravaioli; A. D. Pinna
- Book ID
- 114806018
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 286 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1600-6135
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The allocation rules for patients with hepatocellular carcinoma (HCC) who are awaiting liver transplantation (LT) are a difficult issue and are continually evolving. To reduce tumor progression or down-stage advanced disease, most transplant centers have adopted the practice of treating HCC candidat
Slow-growing tumors have the best prognosis. It is increasingly clear that hepatitis B and C play a role in the develop-Hepatocellular carcinoma (HCC), one of the most frequent ment and progression of HCC both before and after liver malignant tumors in the world, can be fatal if untreated. transplan
The efficacy of orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC) associated with hepatitis C virus (HCV) is not well defined. This study examines the variables that may determine the outcome of OLT for HCC in HCV patients. From 1990 to 1999, 463 OLTs were performed for HCV c